Estrogens, Conjugated Synthetic B: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Estrogens, Conjugated Synthetic B. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Paresthesia | 0% |
| Bronchitis | 0% |
| Breast pain | 0% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
ENJUVIA tablets are indicated in the: Treatment of moderate to severe vasomotor symptoms associated with menopause. Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. When prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.
Source: FDA labeling via NIH DailyMed (set c0625060…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.